Repligen

Visual Financials
Company Name: Repligen Corp
Ticker Symbol: RGEN
CIK Number: 0000730272
WWW Address: https://www.repligen.com
CEO: Mr. Tony J. Hunt
No. of Employees: 236
Common Issue Type: CS
Business Description:Repligen Corporation is a life sciences company engaged in the development, manufacture & sale of consumable bioprocessing products for life sciences companies & biopharmaceutical manufacturing companies worldwide. It also supplies growth factor products.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 77.5 Up 3.28 77.55 79.78 74.31 76.83 74.52 706229
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 3,660.0 47.2 0.00 0.38 0.00 176.4 0.0 77.91 - 43.02
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close74.99$
PE Ratio - LTM176.4
Market Capitalisation3,660.0mil
Latest Shares Outstanding47.2mil
Earnings pS (EPS)0.38$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee354,073$
Effective Tax Rate0.2%
Float38.3mil
Float as % of Shares Outstanding0.9%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.10%
Gross Profit Margin55.4%
EBITDA Margin22.6%
Pre-Tax Profit Margin0.0%
Assets Turnover25.6%
Return on Assets (ROA)2.2%
Return on Equity (ROE)2.8%
Return on Capital Invested (ROCI)3.1%
Current Ratio2.1
Leverage Ratio (Assets/Equity)1.3
Interest Cover4.2
Total Debt/Equity (Gearing Ratio)0.17
LT Debt/Total Capital0.0%
Working Capital pS3.09$
Cash pS0.00$
Book-Value pS13.23$
Tangible Book-Value pS3.25$
Cash Flow pS0.89$
Free Cash Flow pS0.54$
KEY FIGURES (LTM): Price info
Price/Book Ratio5.20
Price/Tangible Book Ratio0.00
Price/Cash Flow76.9
Price/Free Cash Flow128.2
P/E as % of Industry Group60.0%
P/E as % of Sector Segment12.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---7.9536,1922,764,098
4 Weeks77.9165.6369.288.2446,9158,491,394
13 Weeks77.9152.8756.7332.2397,25825,027,306
26 Weeks77.9148.2661.2622.4379,59047,069,171
52 Weeks77.9143.0244.2469.5382,96695,741,534
YTD77.9149.07-45.1354,35038,269,855
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
72.6271.2164.2760.3259.150.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.230.50.32
Income0.010.00.21
Dividend0.0
Capital Spending0.05NA0.30
R&D0.33NA-9.71
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %28.328.3165.5
Earnings %90.690.60.0
EPS %75.075.00.0
EPS $0.030.030.50
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio18.83
Current Ratio2.1
Quick Ratio (Acid Test)1.8
Liquidity Ratio (Cash)2.99
Receivables Turnover6.4
Average Collection Period56
Working Capital/Equity23.7
Working Capital pS3.32
Cash-Flow pS0.72
Free Cash-Flow pS0.41
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.68
Financial Leverage Ratio (Assets/Equity)0.2
Debt Ratio13.4
Total Debt/Equity (Gearing Ratio)0.17
LT Debt/Equity0.00
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities0.0
Interest Cover4.2
Interest/Capital Invested1.09
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio4.20
Current P/E Ratio - LTM176.40
Enterprise Value (EV)/EBITDA65.21
Enterprise Value (EV)/Free Cash Flow163.26
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM5.20
Price/Cash Flow Ratio76.9
Price/Free Cash Flow Ratio - LTM128.2
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM18.9
P/E Ratio (26 weeks ago) - LTM79.8
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio154.8
5-Y Low P/E Ratio39.6
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E54
P/E as % of Industry Group60.0
P/E as % of Sector Segment12.0
Current 12 Month Normalized P/E Ratio - LTM16.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS3.89
Tangible Book Value pS - LTM3.25
Book Value pS - LTM13.23
Capital Invested pS15.23
Cash pS - LTM0.00
Cash Flow pS - LTM0.89
Free Cash Flow pS - LTM0.54
Earnings pS (EPS)0.38
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin9.65
Free Cash Flow Margin 5YEAR AVG11.24
Net Profit Margin0.1
Net Profit Margin - 5YEAR AVRG.0.1
Equity Productivity0.32
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.0.1
Capital Invested Productivity0.27
Return on Capital Invested (ROCI)0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity0.30
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin55.4
Gross Profit Margin - 5YEAR AVRG.0.6
EBITDA Margin - LTM22.6
EBIT Margin - LTM14.5
Pre-Tax Profit Margin0.1
Pre-Tax Profit Margin - 5YEAR AVRG.0.1
Effective Tax Rate18.9
Effective Tax Rate - 5YEAR AVRG.33.6
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee354,073
Net Income per Employee30,323
Average Collection Period
Receivables Turnover6.4
Day's Inventory Turnover Ratio
Inventory Turnover2.1
Inventory/Sales21.8
Accounts Payble/Sales5.41
Assets/Revenue3.33
Net Working Capital Turnover1.33
Fixed Assets Turnover0.39
Total Assets Turnover0.3
Revenue per $ Cash1.00
Revenue per $ Plant6.03
Revenue per $ Common Equity0.32
Revenue per $ Capital Invested0.27
Selling, General & Adm/tive (SG&A) as % of Revenue33.9
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue8.2
R&D Expense as % of Revenue - 5YEAR AVRG.8.2

  


Your Recent History
NASDAQ
RGEN
Repligen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.